<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39391797</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-3546</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Brain, behavior, &amp; immunity - health</Title><ISOAbbreviation>Brain Behav Immun Health</ISOAbbreviation></Journal><ArticleTitle>Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19.</ArticleTitle><Pagination><StartPage>100855</StartPage><MedlinePgn>100855</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100855</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbih.2024.100855</ELocationID><Abstract><AbstractText>Even though respiratory dysfunctions are the primary symptom associated with SARS-CoV-2 infection, cerebrovascular events, and neurological symptoms are described in many patients. However, the connection between the neuroimmune profile and the lung's inflammatory condition during COVID-19 and its association with the neurological symptoms reported by COVID-19 patients still needs further exploration. The present study characterizes the SARS-CoV-2 infectivity profile in <i>postmortem</i> nervous and lung tissue samples of patients who died due to severe COVID-19, and the pro-inflammatory factors present in both nervous and lung tissue samples, via a proteomic profiling array. Additionally, Brain-Derived Neurotrophic Factor (BDNF) levels and intracellular pathways related to neuroplasticity/neuroprotection were assessed in the samples. Out of the 16 samples analyzed, all samples but 1 were positive for the viral genome (genes E or N2, but only 3.9% presented E and N2) in the olfactory brain pathway. The E or N2 gene were also detected in all lung samples, with 43.7% of the samples being positive for the E and N2 genes. In the E/N2 positive brain samples, the Spike protein of SARS-CoV-2 co-localized with TUJ-1+ (neuron-specific class III beta-tubulin) and GFAP+ (glial fibrillary acidic protein) astrocytes. IL-6, but not IL-10, expression was markedly higher in most nervous tissue samples compared to the lung specimens. While intracellular adhesion molecule-1 (ICAM-1), interleukin-8 (IL-8), macrophage migration inhibitory factor (MIF), and plasminogen activator inhibitor 1 (PAI-1) were increased in lung samples from SARS-Cov-2 patients, only MIF and IL-18 were detected in nervous tissue samples. Correlation analysis suggested that high levels of IL-6 are followed by increased levels of IL-10 in the brain, but not in lung samples. Our analysis also demonstrated that the presence of comorbidities, such as cardiovascular disease, hypertension, and hypothyroidism, is associated with neuroinflammation, while chronic kidney conditions predict the presence of neurological symptoms, which correlate with lower levels of BDNF in the brain samples. Our results corroborate the hypothesis that a pro-inflammatory state might further impair neural homeostasis and induce brain abnormalities found in COVID-19 patients.</AbstractText><CopyrightInformation>© 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Rafael R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Pharmacology- Ribeirão Preto Medical School- University of São Paulo, Ribeirão Preto, São Paulo, Brazil, 3900, Bandeirantes Avenue- Monte Alegre- Ribeirão Preto-SP-Brazil - 14049-900.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Ronaldo B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, Ribeirão Preto School of Medicine, University of Sao Paulo, Ribeirão Preto, 3900, Bandeirantes Avenue- Monte Alegre- Ribeirão Preto-SP-Brazil, 14049-900, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pires</LastName><ForeName>Isabela</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pharmacology- Ribeirão Preto Medical School- University of São Paulo, Ribeirão Preto, São Paulo, Brazil, 3900, Bandeirantes Avenue- Monte Alegre- Ribeirão Preto-SP-Brazil - 14049-900.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marques</LastName><ForeName>Bruno L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Department of Pharmacology- Ribeirão Preto Medical School- University of São Paulo, Ribeirão Preto, São Paulo, Brazil, 3900, Bandeirantes Avenue- Monte Alegre- Ribeirão Preto-SP-Brazil - 14049-900.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Karla C M</ForeName><Initials>KCM</Initials><AffiliationInfo><Affiliation>Department of Pharmacology- Ribeirão Preto Medical School- University of São Paulo, Ribeirão Preto, São Paulo, Brazil, 3900, Bandeirantes Avenue- Monte Alegre- Ribeirão Preto-SP-Brazil - 14049-900.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lirio</LastName><ForeName>Pedro H C</ForeName><Initials>PHC</Initials><AffiliationInfo><Affiliation>Department of Pharmacology- Ribeirão Preto Medical School- University of São Paulo, Ribeirão Preto, São Paulo, Brazil, 3900, Bandeirantes Avenue- Monte Alegre- Ribeirão Preto-SP-Brazil - 14049-900.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scomparin</LastName><ForeName>Davi S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Pharmacology- Ribeirão Preto Medical School- University of São Paulo, Ribeirão Preto, São Paulo, Brazil, 3900, Bandeirantes Avenue- Monte Alegre- Ribeirão Preto-SP-Brazil - 14049-900.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scarante</LastName><ForeName>Franciele F</ForeName><Initials>FF</Initials><AffiliationInfo><Affiliation>Department of Pharmacology- Ribeirão Preto Medical School- University of São Paulo, Ribeirão Preto, São Paulo, Brazil, 3900, Bandeirantes Avenue- Monte Alegre- Ribeirão Preto-SP-Brazil - 14049-900.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Batah</LastName><ForeName>Sabrina S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, 3900, Bandeirantes Avenue - Monte Alegre- Ribeirão Preto-SP-Brazil, 14049-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hallak</LastName><ForeName>Jaime E C</ForeName><Initials>JEC</Initials><AffiliationInfo><Affiliation>Department of Neuroscience and Behavior, Faculty of Medicine of Ribeirão Preto, University of São Paulo, 2650, Tenente Catão Roxo Street - Monte Alegre, Ribeirão Preto - SP- Brazil, 14051-140, São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Science and Technology for Translational Medicine (INCT TM) - CNPQ/FAPESP/CAPES - Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crippa</LastName><ForeName>Jose A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Neuroscience and Behavior, Faculty of Medicine of Ribeirão Preto, University of São Paulo, 2650, Tenente Catão Roxo Street - Monte Alegre, Ribeirão Preto - SP- Brazil, 14051-140, São Paulo, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Science and Technology for Translational Medicine (INCT TM) - CNPQ/FAPESP/CAPES - Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Livia C M</ForeName><Initials>LCM</Initials><AffiliationInfo><Affiliation>Department of Physiological Sciences, Health Sciences Center, Universidade Federal do Espírito Santo, Vitória 1468, Marechal Campos Avenue - Maruípe, Vitória, ES, 29047-105, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tostes</LastName><ForeName>Rita C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Pharmacology- Ribeirão Preto Medical School- University of São Paulo, Ribeirão Preto, São Paulo, Brazil, 3900, Bandeirantes Avenue- Monte Alegre- Ribeirão Preto-SP-Brazil - 14049-900.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fabro</LastName><ForeName>Alexandre T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Pathology and Legal Medicine, Ribeirão Preto Medical School, University of São Paulo, 3900, Bandeirantes Avenue - Monte Alegre- Ribeirão Preto-SP-Brazil, 14049-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arruda</LastName><ForeName>Eurico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cell and Molecular Biology, Ribeirão Preto School of Medicine, University of Sao Paulo, Ribeirão Preto, 3900, Bandeirantes Avenue- Monte Alegre- Ribeirão Preto-SP-Brazil, 14049-900, São Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos</LastName><ForeName>Alline C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Pharmacology- Ribeirão Preto Medical School- University of São Paulo, Ribeirão Preto, São Paulo, Brazil, 3900, Bandeirantes Avenue- Monte Alegre- Ribeirão Preto-SP-Brazil - 14049-900.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Science and Technology for Translational Medicine (INCT TM) - CNPQ/FAPESP/CAPES - Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Behav Immun Health</MedlineTA><NlmUniqueID>101759062</NlmUniqueID><ISSNLinking>2666-3546</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BDNF</Keyword><Keyword MajorTopicYN="N">Cardiovascular disease</Keyword><Keyword MajorTopicYN="N">Kidney disease</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Severe COVID-19</Keyword></KeywordList><CoiStatement>We, the authors, attest that there is no conflict of interest associated with this study. The authors have no financial or personal relationships with other individuals or organizations that may influence professional judgment concerning the essential values and the experimental design of our study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>4</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39391797</ArticleId><ArticleId IdType="pmc">PMC11466569</ArticleId><ArticleId IdType="doi">10.1016/j.bbih.2024.100855</ArticleId><ArticleId IdType="pii">S2666-3546(24)00133-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arbour N., Day R., Newcombe J., Talbot P.J. Neuroinvasion by human respiratory coronaviruses. J. Virol. 2000;74(19):8913–8921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC102086</ArticleId><ArticleId IdType="pubmed">10982334</ArticleId></ArticleIdList></Reference><Reference><Citation>Azkur A.K., Akdis M., Azkur D., Sokolowska M., van de Veen W., Brüggen M.C., et al. Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19. Allergy. 2020;75(7):1564–1581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272948</ArticleId><ArticleId IdType="pubmed">32396996</ArticleId></ArticleIdList></Reference><Reference><Citation>BECKMAN Danielle, et al. SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19. Cell Rep. 2022;41(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9554328</ArticleId><ArticleId IdType="pubmed">36288725</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlini V., Noonan D.M., Abdalalem E., Goletti D., Sansone C., Calabrone L., Albini A. The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions. Front. Immunol. 2023;14 doi: 10.3389/fimmu.2023.1161067. PMID: 37359549; PMCID: PMC10287165.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1161067</ArticleId><ArticleId IdType="pmc">PMC10287165</ArticleId><ArticleId IdType="pubmed">37359549</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu S.S., Chan K.H., Chu K.W., Kwan S.W., Guan Y., Poon L.L.M., Peiris J.S.M. Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China. Clin. Infect. Dis. 2005;40:1721–1729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107956</ArticleId><ArticleId IdType="pubmed">15909257</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosentino G., Todisco M., Hota N., Della Porta G., Morbini P., Tassorelli C., et al. Neuropathological findings from COVID‐19 patients with neurological symptoms argue against a direct brain invasion of SARS‐CoV‐2: a critical systematic review. Eur. J. Neurol. 2021;28(11):3856–3865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8444743</ArticleId><ArticleId IdType="pubmed">34339563</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly J.L., Simonetti B., Klein K., Chen K.-E., Williamson M.K., Antón-Plágaro C., et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020;370(6518):861–865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612957</ArticleId><ArticleId IdType="pubmed">33082294</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong L., Xu P., Liu A. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020. Brain Behav. Immun. 2020;87:33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162766</ArticleId><ArticleId IdType="pubmed">32305574</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmi A., Rizzo S., Barzon L., Sandre M., Carturan E., Sinigaglia A., et al. Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei. npj Parkinson's Disease. 2023;9(1):25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9924897</ArticleId><ArticleId IdType="pubmed">36781876</ArticleId></ArticleIdList></Reference><Reference><Citation>Espíndola O.M., Gomes Y.C., Brandão C.O., Torres R.C., Siqueira M., Soares C.N., et al. Inflammatory cytokine patterns associated with neurological diseases in coronavirus disease 2019. Ann. Neurol. 2021;89(5):1041–1045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014707</ArticleId><ArticleId IdType="pubmed">33547819</ArticleId></ArticleIdList></Reference><Reference><Citation>Fotuhi M., Mian A., Meysami S., Raji C.A. Neurobiology of COVID-19. J. Alzheim. Dis. 2020;76(1):3–19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7660990</ArticleId><ArticleId IdType="pubmed">32538857</ArticleId></ArticleIdList></Reference><Reference><Citation>HARPER Justin, et al. Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy. J. Clin. Investig. 2022;132(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9012284</ArticleId><ArticleId IdType="pubmed">35230978</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C., et al. Neurologic features in severe SARS-CoV-2 infection. N. Engl. J. Med. 2020;382(23):2268–2270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>HOU Yuxin, et al. Enhanced replication of SARS-CoV-2 Omicron BA. 2 in human forebrain and midbrain organoids. Signal Transduct. Targeted Ther. 2022;7(1):381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9676899</ArticleId><ArticleId IdType="pubmed">36411276</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Huang S., Yin L. The cytokine storm and COVID‐19. J. Med. Virol. 2021;93(1):250–256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.H., Jiang D., Huang J.T. SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis. Brain Behav. Immun. 2020;87:149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202824</ArticleId><ArticleId IdType="pubmed">32387508</ArticleId></ArticleIdList></Reference><Reference><Citation>ISLAM Hashim, et al. Elevated interleukin-10 levels in COVID-19: potentiation of pro-inflammatory responses or impaired anti-inflammatory action? Front. Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8255680</ArticleId><ArticleId IdType="pubmed">34234779</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M., Yoo S.-J., Clijsters M., Backaert W., Vanstapel A., Speleman K., et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell. 2021;184(24):5932–5949. e15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8564600</ArticleId><ArticleId IdType="pubmed">34798069</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Li H., Fan R., et al. Coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children. Intervirology. 2016;59:163–169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179523</ArticleId><ArticleId IdType="pubmed">28103598</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima Giacobbo B., Doorduin J., Klein H.C., Dierckx R.A., Bromberg E., de Vries E.F. Brain-derived neurotrophic factor in brain disorders: focus on neuroinflammation. Mol. Neurobiol. 2019;56:3295–3312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6476855</ArticleId><ArticleId IdType="pubmed">30117106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Li X., Geng D., Mei N., Wu P.-Y., Huang C.-C., et al. Cerebral micro-structural changes in COVID-19 patients–an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J., Lütgehetmann M., Hagel C., Sperhake J.P., Schröder A.S., Edler C., et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919–929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021;24(2):168–175.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamadian M., Chiti H., Shoghli A., Biglari S., Parsamanesh N., Esmaeilzadeh A. COVID‐19: virology, biology and novel laboratory diagnosis. J. Gene Med. 2021;23(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7883242</ArticleId><ArticleId IdType="pubmed">33305456</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore J.B., June C.H. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473–474.</Citation><ArticleIdList><ArticleId IdType="pubmed">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray R.S., Brown B., Brain D., Cabirac G.F. Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann. Neurol.: Official Journal of the American Neurological Association and the Child Neurology Society. 1992;31(5):525–533.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159714</ArticleId><ArticleId IdType="pubmed">1596089</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka Y., Ueda A., Nakagawa T., Kikuchi Y., Inoue D., Marumo S., et al. SARS-CoV-2-related progressive brain white matter lesion associated with an increased cerebrospinal fluid level of IL-6. Intern. Med. 2021;60(19):3167–3170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8545645</ArticleId><ArticleId IdType="pubmed">34373382</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontelli C., Castro A., Martins B., et al. SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients. J. Mol. Cell Biol. 2022;14(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9384834</ArticleId><ArticleId IdType="pubmed">35451490</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles V.G., Lütgehetmann M., Lindenmeyer M.T., Sperhake J.P., Wong M.N., Allweiss L., et al. Multiorgan and renal tropism of SARS-CoV-2. N. Engl. J. Med. 2020;383(6):590–592.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai S.N., Dilnashin H., Birla H., et al. The role of PI3K/akt and ERK in neurodegenerative disorders. Neurotox. Res. 2019;35(3):775–795. doi: 10.1007/s12640-019-0003-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-019-0003-y</ArticleId><ArticleId IdType="pubmed">30707354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishna K., Nalla L.V., Naresh D., et al. WNT-Β catenin signaling as a potential therapeutic target for neurodegenerative diseases: current status and future perspective. Diseases. 2023;11(3):89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10366863</ArticleId><ArticleId IdType="pubmed">37489441</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F., Maglio M., Landini M.P., Fini M. Body localization of ACE-2: on the trail of the keyhole of SARS-CoV-2. Front. Med. 2020;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7744810</ArticleId><ArticleId IdType="pubmed">33344479</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M., Salié H., Tanevski J., Killmer S., Lago M.S., Schlaak A.E., et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021;54(7):1594–1610. e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>SERRANO Geidy E., et al. SARS-CoV-2 brain regional detection, histopathology, gene expression, and immunomodulatory changes in decedents with COVID-19. J. Neuropathol. Exp. Neurol. 2022;81(9):666–695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9278252</ArticleId><ArticleId IdType="pubmed">35818336</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P., Rai S.N. Factors affecting obesity and its treatment. Obesity Medicine. 2019;16</Citation></Reference><Reference><Citation>Singh N., Rai S.N., Singh V., Singh M.P. Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19. J. Chem. Neuroanat. 2020;110</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7571424</ArticleId><ArticleId IdType="pubmed">33091590</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon I.H., Normandin E., Bhattacharyya S., Mukerji S.S., Keller K., Ali A.S., et al. Neuropathological features of covid-19. N. Engl. J. Med. 2020;383(10):989–992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304421</ArticleId><ArticleId IdType="pubmed">32530583</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 2021;218(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.-Y., Singh M., Yinda C.K., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022:1–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay M.Z., Poh C.M., Rénia L., MacAry P.A., Ng L.F. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 2020;20(6):363–374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderheiden A., Klein R.S. Neuroinflammation and COVID-19. Curr. Opin. Neurobiol. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9239981</ArticleId><ArticleId IdType="pubmed">35863101</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A., Thomas N., Ellul M.A., Davies N.W., Pollak T.A., Tenorio E.L., et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatr. 2020;7(10):875–882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Yang Q., Chi J., Dong B., Lv W., Shen L., et al. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: a systematic review and meta-analysis. Int. J. Infect. Dis. 2020;99:47–56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381888</ArticleId><ArticleId IdType="pubmed">32721533</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>